Atossa Therapeutics Inc (ATOS)
1.66
+0.14
(+9.21%)
USD |
NASDAQ |
May 03, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics Cash from Operations (Quarterly): -5.571M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.571M |
| September 30, 2023 | -3.883M |
| June 30, 2023 | -4.465M |
| March 31, 2023 | -7.022M |
| December 31, 2022 | -4.523M |
| September 30, 2022 | -5.41M |
| June 30, 2022 | -5.949M |
| March 31, 2022 | -4.878M |
| December 31, 2021 | -3.665M |
| September 30, 2021 | -3.062M |
| June 30, 2021 | -5.337M |
| March 31, 2021 | -4.408M |
| December 31, 2020 | -3.432M |
| September 30, 2020 | -2.678M |
| June 30, 2020 | -2.229M |
| March 31, 2020 | -3.23M |
| December 31, 2019 | -2.708M |
| September 30, 2019 | -1.769M |
| June 30, 2019 | -2.502M |
| March 31, 2019 | -2.149M |
| December 31, 2018 | -2.444M |
| September 30, 2018 | -2.298M |
| June 30, 2018 | -1.833M |
| March 31, 2018 | -2.387M |
| December 31, 2017 | -1.683M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.702M |
| June 30, 2017 | -1.349M |
| March 31, 2017 | -1.861M |
| December 31, 2016 | -1.356M |
| September 30, 2016 | 0.6355M |
| June 30, 2016 | -1.659M |
| March 31, 2016 | -2.995M |
| December 31, 2015 | -3.953M |
| September 30, 2015 | -3.481M |
| June 30, 2015 | -3.521M |
| March 31, 2015 | -2.999M |
| December 31, 2014 | -2.719M |
| September 30, 2014 | -2.978M |
| June 30, 2014 | -2.254M |
| March 31, 2014 | -2.604M |
| December 31, 2013 | -2.648M |
| September 30, 2013 | -2.738M |
| June 30, 2013 | -2.109M |
| March 31, 2013 | -1.335M |
| December 31, 2012 | -1.932M |
| September 30, 2012 | -0.151M |
| June 30, 2012 | -0.8115M |
| March 31, 2012 | -1.005M |
| December 31, 2011 | -1.039M |
| September 30, 2011 | -1.344M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-7.022M
Minimum
Mar 2023
-1.769M
Maximum
Sep 2019
-4.038M
Average
-3.883M
Median
Sep 2023
Cash from Operations (Quarterly) Benchmarks
| AngioDynamics Inc | -12.53M |
| Achieve Life Sciences Inc | -4.364M |
| Biolase Inc | -2.283M |
| Outset Medical Inc | -24.44M |
| Perspective Therapeutics Inc | -9.008M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | -20.96M |
| Free Cash Flow Per Share (Quarterly) | -0.0445 |
| Free Cash Flow Yield | -10.01% |